Cardia Health
Heart-failure management for risk-bearing primary care. Live in 11 hospital systems. Reduces 30-day readmissions by 34% in the published RCT.
Five companies pitched. Eight judges deliberated until 2am. By breakfast Sunday, the cheque was on the table. Here’s what happened, who won, and what the room is doing twelve months later.
01 /Recap
A short film cut from 14 hours of footage by Field Notes. The pitches, the deliberation room, the moment Cardia’s Sarah Yoon learned she’d won.
02 /Impact
Twelve months after the cheque cleared. Numbers verified by GHF; raised totals confirmed by founders and lead investors as of October 2026.
From 34 countries; reviewed by all 22 judges. 89% read by the panel themselves — not by associates.
Across the cohort of five, in the twelve months following the event. Lead rounds from a16z, Andreessen Bio, Foresite, and 7wire.
Across the five portfolio companies. Counts only patients who used the product, not impressions.
Live, paying customers — not pilots. Includes Cleveland Clinic, Kaiser, Mayo, Mount Sinai, and Geisinger.
From entry round to most recent priced round. Trailing twelve months, cohort median.
Net headcount growth across the five portfolio companies. 64% are clinical or operational; 36% engineering.
03 /Cohort
Selected from 847 applications by the panel of eight. Each one ran through three sector interviews, two diligence calls, and the final pitch.
Heart-failure management for risk-bearing primary care. Live in 11 hospital systems. Reduces 30-day readmissions by 34% in the published RCT.
Ambient documentation purpose-built for surgical specialties. 8,400 surgeons live; integrated into Epic and Cerner.
At-home blood diagnostic for hematologic malignancies. CLIA-certified; 14,000 tests run; first commercial deployment with Memorial Sloan Kettering.
Group therapy at scale, employer-paid. 240,000 covered lives across 22 self-insured employers. Engagement: 41% MAU.
VBC contract management infrastructure for ACOs and risk-bearing groups. $14B in attributed lives runs through Plinth's reconciliation engine.
04 /Stages
The order, the moment that mattered, the scoreline. Each founder had 12 minutes to pitch and 18 to take questions. The room kept the timer.
Sarah Yoon, CEO & co-founder
“We're not a tool you bolt onto a primary-care practice. We're the cardiology line item on their capitated P&L.”
9.1 / 10 panel score
Naveen Patel, CEO & co-founder
“Every other ambient tool is built for the clinic. The OR is a different problem — and ours is the only product surgeons actually keep on after the pilot ends.”
8.4 / 10 panel score
Dr. Lily Chen, CEO & chief scientist
“You can find leukemia from a finger-prick if you have the right assay. We have the right assay. The remaining problem is logistics, and that's a problem we love.”
8.2 / 10 panel score
Marcus Hill, CEO & co-founder
“1:1 therapy isn't scarce because there aren't enough therapists. It's scarce because the unit isn't built for the work. The unit should be a group of eight.”
7.9 / 10 panel score
Anya Petrova, CEO & co-founder
“Risk contracts get signed. Then nobody actually figures out what each side owes. That's a $14B reconciliation problem and we solved it.”
8.0 / 10 panel score
05 /Network
Twenty-eight firms attended in person. Eleven of them led or co-led a follow-on round in a Venture Forum 2025 cohort company within twelve months.
06 /Candid
Photos by Field Notes. The lobby, the library, the cheque. Real headshots and frames will replace these placeholder cells when the gallery opens.
07 /Pulse
Coverage selected for substance, not flattery. The full press archive lives in the GHF newsroom; the six below are the pieces we keep coming back to.
08 /Growth
Reported by founders; verified by lead investors. The cohort doesn’t grade itself — these are real numbers as of October 2026.
Eleven hospital systems live; two more in security review. RCT data published in JAMA Cardiology shows 34% reduction in 30-day readmissions across attributed lives.
Live with 8,400 surgeons across 22 systems. Net revenue retention at 142%. The Epic App Orchard listing went live in July.
14,000 tests run; CLIA-certified across two reference labs. First commercial deployment with MSK closed; Mayo deployment scheduled for Q1.
240k covered lives across 22 self-insured employers. 41% MAU is the highest engagement number in the digital mental health category, per Rock Health's 2026 benchmark.
$14B in attributed lives runs through Plinth. Strategic round signals Optum's intent to standardize on the Plinth reconciliation API across its risk-bearing groups.
Reported quarterly to GHF and aggregated against the public Venture Forum scorecard. Median valuation lift across the five companies is 3.8× from entry to most recent round.